SEARCH

SEARCH BY CITATION

References

  • 1
    Steimman RM. The dendritic cells system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 27196.
  • 2
    Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW. Fas-ligand (CD95) and B7 experssion on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997; 158: 567684.
  • 3
    Trinite B, Voisine C., Yagita H, Josien R. A subset of cytolytic dendritic cell in rat. J Immunol 2000; 165: 42028.
  • 4
    Chapoval AI, Tanada K, Chen L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 2000; 95: 234654.
  • 5
    Kato T, Yamane H, Nariuchi H. Differential effects of LPS and CD40 ligand stimulations on the induction of IL-12 production by dendritic cells and macrophages. Cell Immunol 1997; 181: 5967.
  • 6
    Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 1999; 162: 16875.
  • 7
    Liu S, Yu Y, Zhang M, Wang W, Cao X. The involvement of TNF-α related apiptosis-inducing ligand in the enhanced cytotoxivity of IFN-β-stimulated human dendritic cells to tumor cells. J Immunol 2001; 166: 540715.
  • 8
    Fanger NA, Maliszewski CR, Schooley K, Griffith TS. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med 1999; 190: 115564.
  • 9
    Lu G, Janjic BM, Janjic J, Whiteside TL, Storkus WJ, Vujanovic NL. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, Lymphotoxin-α1β2, Fas Ligand, and TNF-related apoptosis-inducing ligand. J Immunol 2002; 168: 18319.
  • 10
    Janjic BM, Lu G, Pimenov A, Whiteside TL, Storkus WJ, Vujanovic NL. Innate direct anticancer effect function of human immarure dendritic cells. 1. Involvement of an apoptosis-inducing pathway. J Immunol 2002; 168: 182330.
  • 11
    Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 8393.
  • 12
    Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J. Lymphotactin gene-, modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. J Immunol 1998; 161: 623844.
  • 13
    Karanikas V, Lodding J, Maino VC, McKenzie IF. Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Clin Cancer Res 2000; 6: 82937.
  • 14
    Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yagita SH, Okumura K. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 1994; 91: 49304.
  • 15
    Strunk D, Rappersberger K, Egger C, Strobl H, Kromer E, Elbe A, Maurer D, Stingl G. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 1996; 87: 1292302.
  • 16
    Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997; 27: 43141.
  • 17
    Crespo I, Paiva A, Couceiro A, Pimentel P, Orfao A, Regateiro F. Immunophenotypic and functional characterization of cord blood dendritic cells. Stem Cells Dev 2004; 13: 6370.
  • 18
    Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of porent immunostimulatory dendritic cells under fetal calf-serum-free conditions. Eur J Immunol 1997; 27: 313542.
  • 19
    Vidalain PO, Azocar H, Yagita H, Rabourdin-Combe C, Sevet-Delprat C. Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. J Immunol 2001; 167: 376572.
  • 20
    Vujanovic NL, Nagashima S, Herberman RB, Whiteside TL. Nonsecretory apoptotic killing by human NK cells. J Immunol 1996; 157: 111726.
  • 21
    Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine TRAIL. J Exp Med 1999; 189: 134354.
  • 22
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 1999; 163: 190913.
  • 23
    Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, Servet-Delprat C. Measles virus induces functional TRAIL production by human dendritic cells. J Virol 2000; 74: 5569.
  • 24
    Liu E, Tu W, Law HK, Lau YL. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol 2001; 113: 2406.
  • 25
    Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 1268790.
  • 26
    Nathalie V, Ezea A, Zoulikha A, Peter V, Micherl G, Fabienne W. Tummoricidal activity of monocyte-derived dendritic cells: evidence for a casoase-8-deoendent, Fas-associated death domain-independent mechanism. J Immunol 2001; 167: 35659.
  • 27
    Ayres FM, Narita M, Takahashi M, Yano T, Liu A, Toba K, Furukawa T, Aizawa Y. Human dendritic cells mediate anti-tumor activity against hematopoietic tumor cells without direct contact and Fas/FasL killing pathway. Oncol Rep 2004; 11: 101723.
  • 28
    Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 1999; 163: 535866.
  • 29
    Burdin N, Peronne C, Banchereau J, Rousset F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 1993; 177: 295304.